Two Sigma Investments
ONCY

Two Sigma Investments’s Oncolytics Biotech ONCY Stock Holding History

Two Sigma Investments’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-25,200
Closed -$70K – 4571
2021
Q2 		$70K Buy
+25,200
New +$77.2K ﹤0.01% 3935

Other funds holding ONCY

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Two Sigma Investments's ONCY Position: Q3 2021 in Review

Two Sigma Investments sold out of Oncolytics Biotech (ONCY) in Q3 2021, closing a stake of 25,200 shares — an estimated $70K sold.

Two Sigma Investments first reported a position in ONCY in Q2 2021 and held it in 1 quarter. The position peaked at $70K in Q2 2021. 37 funds tracked by Wall St. Rank hold ONCY as of Q3 2021.

  • Two Sigma Investments reported no remaining Oncolytics Biotech position as of Q3 2021 after selling out during the quarter.
  • Two Sigma Investments sold 25,200 Oncolytics Biotech shares in Q3 2021, an estimated $70K.
  • Two Sigma Investments first reported a position in Oncolytics Biotech in Q2 2021 and held it in 1 quarter.
  • Two Sigma Investments's Oncolytics Biotech position peaked at $70K in Q2 2021.
  • 37 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q3 2021.

Based on Two Sigma Investments's 13F filing for Q3 2021, filed 15 Nov 2021.